CAXTON ASSOCIATES LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2023$180,361
-10.9%
286,287
-8.2%
0.03%
+92.9%
Q4 2022$202,502
-62.3%
311,9740.0%0.01%
-80.6%
Q3 2022$537,000
+329.6%
311,974
+209.8%
0.07%
+500.0%
Q2 2022$125,000
+35.9%
100,715
-28.7%
0.01%
+71.4%
Q1 2022$92,000
-40.3%
141,2540.0%0.01%
-56.2%
Q4 2021$154,000
+18.5%
141,254
+413.5%
0.02%
-11.1%
Q4 2019$130,00027,5060.02%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders